Guardant Health, Inc. September 16, 2018Guardant Health, Inc. • November 19th, 2018 • Services-medical laboratories
Company FiledNovember 19th, 2018 IndustryThis offer letter (this “Amended Letter”) amends and restates the offer letter between you and Guardant Health, Inc. (the “Company”), dated April 6, 2018 (the “Offer Letter”), in its entirety and will provide the terms under which you will continue to serve as a member of the Board of Directors (the “Board”) of the Company from and after the closing of the initial public offering of the Company’s common stock (the “IPO”).
Guardant Health, Inc. September 16, 2018Guardant Health, Inc. • November 19th, 2018 • Services-medical laboratories
Company FiledNovember 19th, 2018 IndustryThis offer letter (this “Amended Letter”) amends and restates the offer letter between you and Guardant Health, Inc. (the “Company”), dated November 30, 2016 (the “Offer Letter”), in its entirety and will provide the terms under which you will continue to serve as a member of the Board of Directors (the “Board”) of the Company from and after the closing of the initial public offering of the Company’s common stock (the “IPO”).